Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 234

1.

Genetic testing in ALS: A survey of current practices.

Vajda A, McLaughlin RL, Heverin M, Thorpe O, Abrahams S, Al-Chalabi A, Hardiman O.

Neurology. 2017 Feb 3. pii: 10.1212/WNL.0000000000003686. doi: 10.1212/WNL.0000000000003686. [Epub ahead of print]

PMID:
28159885
2.

Visual encoding, consolidation, and retrieval in amyotrophic lateral sclerosis: executive function as a mediator, and predictor of performance.

Burke T, Lonergan K, Pinto-Grau M, Elamin M, Bede P, Madden C, Hardiman O, Pender N.

Amyotroph Lateral Scler Frontotemporal Degener. 2017 Jan 13:1-9. doi: 10.1080/21678421.2016.1272615. [Epub ahead of print]

PMID:
28084080
3.

A genetic overview of Atlantic coastal populations from Europe and North-West Africa based on a 17 X-STR panel.

Prieto-Fernández E, Díaz-de Usera A, Baeta M, Núñez C, Chbel F, Nadifi S, Rouault K, Férec C, Hardiman O, Pinheiro F, de Pancorbo MM.

Forensic Sci Int Genet. 2017 Mar;27:167-171. doi: 10.1016/j.fsigen.2016.11.011.

PMID:
27931869
4.

A population-based epidemiologic study of adult neuromuscular disease in the Republic of Ireland.

Lefter S, Hardiman O, Ryan AM.

Neurology. 2017 Jan 17;88(3):304-313. doi: 10.1212/WNL.0000000000003504.

PMID:
27927941
6.

Screening for cognitive dysfunction in ALS: validation of the Edinburgh Cognitive and Behavioural ALS Screen (ECAS) using age and education adjusted normative data.

Pinto-Grau M, Burke T, Lonergan K, McHugh C, Mays I, Madden C, Vajda A, Heverin M, Elamin M, Hardiman O, Pender N.

Amyotroph Lateral Scler Frontotemporal Degener. 2017 Feb;18(1-2):99-106. doi: 10.1080/21678421.2016.1249887.

PMID:
27894201
7.

Identifying behavioural changes in ALS: Validation of the Beaumont Behavioural Inventory (BBI).

Elamin M, Pinto-Grau M, Burke T, Bede P, Rooney J, O'Sullivan M, Lonergan K, Kirby E, Quinlan E, Breen N, Vajda A, Heverin M, Pender N, Hardiman O.

Amyotroph Lateral Scler Frontotemporal Degener. 2017 Feb;18(1-2):68-73. doi: 10.1080/21678421.2016.1248976.

PMID:
27894191
8.

What does the ALSFRS-R really measure? A longitudinal and survival analysis of functional dimension subscores in amyotrophic lateral sclerosis.

Rooney J, Burke T, Vajda A, Heverin M, Hardiman O.

J Neurol Neurosurg Psychiatry. 2016 Nov 25. pii: jnnp-2016-314661. doi: 10.1136/jnnp-2016-314661. [Epub ahead of print]

PMID:
27888187
9.

C9orf72 expansion differentially affects males with spinal onset amyotrophic lateral sclerosis.

Rooney J, Fogh I, Westeneng HJ, Vajda A, McLaughlin R, Heverin M, Jones A, van Eijk R, Calvo A, Mazzini L, Shaw C, Morrison K, Shaw PJ, Robberecht W, Van Damme P, Al-Chalabi A, van den Berg L, Chiò A, Veldink J, Hardiman O.

J Neurol Neurosurg Psychiatry. 2016 Sep 23. pii: jnnp-2016-314093. doi: 10.1136/jnnp-2016-314093. [Epub ahead of print]

PMID:
27663272
10.

Amyotrophic lateral sclerosis: moving towards a new classification system.

Al-Chalabi A, Hardiman O, Kiernan MC, Chiò A, Rix-Brooks B, van den Berg LH.

Lancet Neurol. 2016 Oct;15(11):1182-94. doi: 10.1016/S1474-4422(16)30199-5. Review.

PMID:
27647646
11.

Caregiving in ALS - a mixed methods approach to the study of Burden.

Galvin M, Corr B, Madden C, Mays I, McQuillan R, Timonen V, Staines A, Hardiman O.

BMC Palliat Care. 2016 Sep 5;15(1):81. doi: 10.1186/s12904-016-0153-0.

12.

Measurement of Social Cognition in Amyotrophic Lateral Sclerosis: A Population Based Study.

Burke T, Pinto-Grau M, Lonergan K, Elamin M, Bede P, Costello E, Hardiman O, Pender N.

PLoS One. 2016 Aug 24;11(8):e0160850. doi: 10.1371/journal.pone.0160850.

13.

The effects of a home-based arm ergometry exercise programme on physical fitness, fatigue and activity in Polio survivors: A randomised controlled trial.

Murray D, Hardiman O, Campion A, Vance R, Horgan F, Meldrum D.

Clin Rehabil. 2016 Aug 16. pii: 0269215516661225. [Epub ahead of print]

PMID:
27530605
14.

Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis.

van Rheenen W, Shatunov A, Dekker AM, McLaughlin RL, Diekstra FP, Pulit SL, van der Spek RA, Võsa U, de Jong S, Robinson MR, Yang J, Fogh I, van Doormaal PT, Tazelaar GH, Koppers M, Blokhuis AM, Sproviero W, Jones AR, Kenna KP, van Eijk KR, Harschnitz O, Schellevis RD, Brands WJ, Medic J, Menelaou A, Vajda A, Ticozzi N, Lin K, Rogelj B, Vrabec K, Ravnik-Glavač M, Koritnik B, Zidar J, Leonardis L, Grošelj LD, Millecamps S, Salachas F, Meininger V, de Carvalho M, Pinto S, Mora JS, Rojas-García R, Polak M, Chandran S, Colville S, Swingler R, Morrison KE, Shaw PJ, Hardy J, Orrell RW, Pittman A, Sidle K, Fratta P, Malaspina A, Topp S, Petri S, Abdulla S, Drepper C, Sendtner M, Meyer T, Ophoff RA, Staats KA, Wiedau-Pazos M, Lomen-Hoerth C, Van Deerlin VM, Trojanowski JQ, Elman L, McCluskey L, Basak AN, Tunca C, Hamzeiy H, Parman Y, Meitinger T, Lichtner P, Radivojkov-Blagojevic M, Andres CR, Maurel C, Bensimon G, Landwehrmeyer B, Brice A, Payan CA, Saker-Delye S, Dürr A, Wood NW, Tittmann L, Lieb W, Franke A, Rietschel M, Cichon S, Nöthen MM, Amouyel P, Tzourio C, Dartigues JF, Uitterlinden AG, Rivadeneira F, Estrada K, Hofman A, Curtis C, Blauw HM, van der Kooi AJ, de Visser M, Goris A, Weber M, Shaw CE, Smith BN, Pansarasa O, Cereda C, Del Bo R, Comi GP, D'Alfonso S, Bertolin C, Sorarù G, Mazzini L, Pensato V, Gellera C, Tiloca C, Ratti A, Calvo A, Moglia C, Brunetti M, Arcuti S, Capozzo R, Zecca C, Lunetta C, Penco S, Riva N, Padovani A, Filosto M, Muller B, Stuit RJ; PARALS Registry.; SLALOM Group.; SLAP Registry.; FALS Sequencing Consortium.; SLAGEN Consortium.; NNIPPS Study Group., Blair I, Zhang K, McCann EP, Fifita JA, Nicholson GA, Rowe DB, Pamphlett R, Kiernan MC, Grosskreutz J, Witte OW, Ringer T, Prell T, Stubendorff B, Kurth I, Hübner CA, Leigh PN, Casale F, Chio A, Beghi E, Pupillo E, Tortelli R, Logroscino G, Powell J, Ludolph AC, Weishaupt JH, Robberecht W, Van Damme P, Franke L, Pers TH, Brown RH, Glass JD, Landers JE, Hardiman O, Andersen PM, Corcia P, Vourc'h P, Silani V, Wray NR, Visscher PM, de Bakker PI, van Es MA, Pasterkamp RJ, Lewis CM, Breen G, Al-Chalabi A, van den Berg LH, Veldink JH.

Nat Genet. 2016 Sep;48(9):1043-8. doi: 10.1038/ng.3622.

PMID:
27455348
15.

NEK1 variants confer susceptibility to amyotrophic lateral sclerosis.

Kenna KP, van Doormaal PT, Dekker AM, Ticozzi N, Kenna BJ, Diekstra FP, van Rheenen W, van Eijk KR, Jones AR, Keagle P, Shatunov A, Sproviero W, Smith BN, van Es MA, Topp SD, Kenna A, Miller JW, Fallini C, Tiloca C, McLaughlin RL, Vance C, Troakes C, Colombrita C, Mora G, Calvo A, Verde F, Al-Sarraj S, King A, Calini D, de Belleroche J, Baas F, van der Kooi AJ, de Visser M, Ten Asbroek AL, Sapp PC, McKenna-Yasek D, Polak M, Asress S, Muñoz-Blanco JL, Strom TM, Meitinger T, Morrison KE; SLAGEN Consortium., Lauria G, Williams KL, Leigh PN, Nicholson GA, Blair IP, Leblond CS, Dion PA, Rouleau GA, Pall H, Shaw PJ, Turner MR, Talbot K, Taroni F, Boylan KB, Van Blitterswijk M, Rademakers R, Esteban-Pérez J, García-Redondo A, Van Damme P, Robberecht W, Chio A, Gellera C, Drepper C, Sendtner M, Ratti A, Glass JD, Mora JS, Basak NA, Hardiman O, Ludolph AC, Andersen PM, Weishaupt JH, Brown RH Jr, Al-Chalabi A, Silani V, Shaw CE, van den Berg LH, Veldink JH, Landers JE.

Nat Genet. 2016 Sep;48(9):1037-42. doi: 10.1038/ng.3626.

PMID:
27455347
16.

Age-period-cohort analysis of trends in amyotrophic lateral sclerosis incidence.

Tobin K, Gilthorpe MS, Rooney J, Heverin M, Vajda A, Staines A, Hardiman O.

J Neurol. 2016 Oct;263(10):1919-26. doi: 10.1007/s00415-016-8215-z.

PMID:
27372451
17.

Association of a Locus in the CAMTA1 Gene With Survival in Patients With Sporadic Amyotrophic Lateral Sclerosis.

Fogh I, Lin K, Tiloca C, Rooney J, Gellera C, Diekstra FP, Ratti A, Shatunov A, van Es MA, Proitsi P, Jones A, Sproviero W, Chiò A, McLaughlin RL, Sorarù G, Corrado L, Stahl D, Del Bo R, Cereda C, Castellotti B, Glass JD, Newhouse S, Dobson R, Smith BN, Topp S, van Rheenen W, Meininger V, Melki J, Morrison KE, Shaw PJ, Leigh PN, Andersen PM, Comi GP, Ticozzi N, Mazzini L, D'Alfonso S, Traynor BJ, Van Damme P, Robberecht W, Brown RH, Landers JE, Hardiman O, Lewis CM, van den Berg LH, Shaw CE, Veldink JH, Silani V, Al-Chalabi A, Powell J.

JAMA Neurol. 2016 Jul 1;73(7):812-20. doi: 10.1001/jamaneurol.2016.1114.

PMID:
27244217
18.

The segmental diffusivity profile of amyotrophic lateral sclerosis associated white matter degeneration.

Schuster C, Elamin M, Hardiman O, Bede P.

Eur J Neurol. 2016 Aug;23(8):1361-71. doi: 10.1111/ene.13038.

PMID:
27207250
19.

Discordant performance on the 'Reading the Mind in the Eyes' Test, based on disease onset in amyotrophic lateral sclerosis.

Burke T, Elamin M, Bede P, Pinto-Grau M, Lonergan K, Hardiman O, Pender N.

Amyotroph Lateral Scler Frontotemporal Degener. 2016 Oct - Nov;17(7-8):467-472.

PMID:
27152765
20.

Survival analysis of geospatial factors in the Irish ALS cohort.

Rooney J, Heverin M, Vajda A, Burke T, Galvin M, Tobin K, Elamin M, Staines A, Hardiman O.

Amyotroph Lateral Scler Frontotemporal Degener. 2016 Oct - Nov;17(7-8):555-560.

PMID:
27145090
Items per page

Supplemental Content

Loading ...
Support Center